J. Virol., Mar 1996, 1564-1569, Vol 70, No. 3
Copyright © 1996, American Society for Microbiology

Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides

Y Sagara, Y Inoue, H Shiraki, A Jinno, H Hoshino and Y Maeda
Fukuoka Red Cross Blood Center, Japan.

To identify the regions that are important in human T-cell leukemia virus type 1 (HTLV-1) envelope function, we synthesized 23 kinds of peptides covering the envelope proteins and examined the inhibitory effect of each peptide on syncytium formation induced by HTLV-1-bearing cells. Of the 23 synthetic peptides, 2, corresponding to amino acids 197 to 216 on gp46 and 400 to 429 on gp21, inhibited syncytium formation induced by HTLV-1-bearing cells but did not affect syncytium formation induced by human immunodeficiency virus type 1-producing cells. The peptide concentrations giving 50% inhibition of syncytium formation for gp46 197 to 216 and gp21 400 to 429 were 14.9 and 6.0 microM, respectively. A syncytium formation assay with overlapping synthetic peptides containing amino acids 175 to 236 and 391 to 448 of the envelope proteins showed that syncytium formation was inhibited by peptides that contained the amino acid sequences 197 to 205 (Asp-His- Ile-Leu-Glu-Pro-Ser-Ile-Pro) and 397 to 406 (Gln-Glu-Gln-Cys-Arg-Phe- Pro-Asn-Ile-Thr). These observations suggest that the two regions corresponding to amino acids 197 to 216 and 400 to 429 are involved] in HTLV-1 envelope function.

This article has been cited by other articles:

• Mirsaliotis, A., Lamb, D., Brighty, D. W. (2008). Nonhelical Leash and {alpha}-Helical Structures Determine the Potency of a Peptide Antagonist of Human T-Cell Leukemia Virus Entry. J. Virol. 82: 4965-4973 [Abstract] [Full Text]  
• Ujike, M., Nishikawa, H., Otaka, A., Yamamoto, N., Yamamoto, N., Matsuoka, M., Kodama, E., Fujii, N., Taguchi, F. (2008). Heptad Repeat-Derived Peptides Block Protease-Mediated Direct Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus but Not Entry via the Endosomal Pathway. J. Virol. 82: 588-592 [Abstract] [Full Text]  
• Mirsaliotis, A., Nurkiyanova, K., Lamb, D., Kuo, C.-W. S., Brighty, D. W. (2007). Resistance to Neutralization by Antibodies Targeting the Coiled Coil of Fusion-active Envelope Is a Common Feature of Retroviruses. J. Biol. Chem. 282: 36724-36735 [Abstract] [Full Text]  
• Takeoka, H., Furusyo, N., Toyoda, K., Murata, M., Sagara, Y., Kashiwagi, S., Hayashi, J. (2007). Antibody to the Human T-Lymphotropic Virus Type 1 (HTLV-1) Envelope Protein Gp46 in Patients Co-infected with HCV and HTLV-1. Am J Trop Med Hyg 77: 192-196 [Abstract] [Full Text]  
• Mirsaliotis, A., Nurkiyanova, K., Lamb, D., Woof, J. M., Brighty, D. W. (2007). Conformation-Specific Antibodies Targeting the Trimer-of-Hairpins Motif of the Human T-Cell Leukemia Virus Type 1 Transmembrane Glycoprotein Recognize the Viral Envelope but Fail To Neutralize Viral Entry. J. Virol. 81: 6019-6031 [Abstract] [Full Text]  
• Mirsaliotis, A., Nurkiyanova, K., Lamb, D., Kuo, C.-W. S., Brighty, D. W. (2007). An antibody that blocks human T-cell leukemia virus type 1 six-helix-bundle formation in vitro identified by a novel assay for inhibitors of envelope function. J. Gen. Virol. 88: 660-669 [Abstract] [Full Text]  
• Amberg, S. M., Netter, R. C., Simmons, G., Bates, P. (2006). Expanded Tropism and Altered Activation of a Retroviral Glycoprotein Resistant to an Entry Inhibitor Peptide. J. Virol. 80: 353-359 [Abstract] [Full Text]  
• Netter, R. C., Amberg, S. M., Balliet, J. W., Biscone, M. J., Vermeulen, A., Earp, L. J., White, J. M., Bates, P. (2004). Heptad Repeat 2-Based Peptides Inhibit Avian Sarcoma and Leukosis Virus Subgroup A Infection and Identify a Fusion Intermediate. J. Virol. 78: 13430-13439 [Abstract] [Full Text]  
• Sundaram, R., Lynch, M. P., Rawale, S. V., Sun, Y., Kazanji, M., Kaumaya, P. T. P. (2004). De Novo Design of Peptide Immunogens That Mimic the Coiled Coil Region of Human T-cell Leukemia Virus Type-1 Glycoprotein 21 Transmembrane Subunit for Induction of Native Protein Reactive Neutralizing Antibodies. J. Biol. Chem. 279: 24141-24151 [Abstract] [Full Text]  
• Pinon, J. D., Kelly, S. M., Price, N. C., Flanagan, J. U., Brighty, D. W. (2003). An Antiviral Peptide Targets a Coiled-Coil Domain of the Human T-Cell Leukemia Virus Envelope Glycoprotein. J. Virol. 77: 3281-3290 [Abstract] [Full Text]  
• Brighty, D. W., Jassal, S. R. (2001). The Synthetic Peptide P-197 Inhibits Human T-Cell Leukemia Virus Type 1 Envelope-Mediated Syncytium Formation by a Mechanism That Is Independent of Hsc70. J. Virol. 75: 10472-10478 [Abstract] [Full Text]  
• Jassal, S. R., Pohler, R. G., Brighty, D. W. (2001). Human T-Cell Leukemia Virus Type 1 Receptor Expression among Syncytium-Resistant Cell Lines Revealed by a Novel Surface Glycoprotein-Immunoadhesin. J. Virol. 75: 8317-8328 [Abstract] [Full Text]  
• Maerz, A. L., Drummer, H. E., Wilson, K. A., Poumbourios, P. (2001). Functional Analysis of the Disulfide-Bonded Loop/Chain Reversal Region of Human Immunodeficiency Virus Type 1 gp41 Reveals a Critical Role in gp120-gp41 Association. J. Virol. 75: 6635-6644 [Abstract] [Full Text]  
• Okuma, K., Matsuura, Y., Tatsuo, H., Inagaki, Y., Nakamura, M., Yamamoto, N., Yanagi, Y. (2001). Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins. J. Gen. Virol. 82: 821-830 [Abstract] [Full Text]  
• Jinno, A., Haraguchi, Y., Shiraki, H., Hoshino, H. (1999). Inhibition of Cell-Free Human T-Cell Leukemia Virus Type 1 Infection at a Postbinding Step by the Synthetic Peptide Derived from an Ectodomain of the gp21 Transmembrane Glycoprotein. J. Virol. 73: 9683-9689 [Abstract] [Full Text]  
• Kobe, B., Center, R. J., Kemp, B. E., Poumbourios, P. (1999). Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc. Natl. Acad. Sci. USA 96: 4319-4324 [Abstract] [Full Text]  
• Ikeda, F., Haraguchi, Y., Jinno, A., Iino, Y., Morishita, Y., Shiraki, H., Hoshino, H. (1998). Human Complement Component C1q Inhibits the Infectivity of Cell-Free HTLV-I. J. Immunol. 161: 5712-5719 [Abstract] [Full Text]  
• Rosenberg, A. R., Delamarre, L., Preira, A., Dokhelar, M.-C. (1998). Analysis of Functional Conservation in the Surface and Transmembrane Glycoprotein Subunits of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2. J. Virol. 72: 7609-7614 [Abstract] [Full Text]  
• Sagara, Y., Ishida, C., Inoue, Y., Shiraki, H., Maeda, Y. (1998). 71-Kilodalton Heat Shock Cognate Protein Acts as a Cellular Receptor for Syncytium Formation Induced by Human T-Cell Lymphotropic Virus Type 1. J. Virol. 72: 535-541 [Abstract] [Full Text]